Preliminary programme

The 2021 FIP congress in Seville, Spain, calls on pharmacy practitioners, pharmaceutical scientists and educators from around the world to gather together to discuss how new technologies will impact medicines and the people who use them. Health care and pharmacy are facing both a global and a technological revolution. Wherever we live, the conversation is the same.

The ongoing need to reduce the costs of care, higher service expectations and advances in how big data can predict disease faster and more accurately all contribute to growing demands on digital health and the use of technology. The technological revolution enables investments in health care that mean we can proactively enable better health and disease prevention, while minimising costs. It also carries with it the prospect of new pharmacy services with the ability to deliver true beyond-the-pill value.
New technologies will continue to change and develop the health care industry as we know it. Smart systems capable of understanding health issues and complicated diseases will lead to innovations that will affect pharmacy in many ways.

On the one hand, innovation will provide new ways of treating diseases, of optimising diagnoses and outcomes, screenings and therapy, and of improving delicate decision-making processes.
On the other, it will also impact the business side providing opportunities for companies and organisations to more accurately and efficiently deliver optimised health care.

Technological advancement will affect pharmacy, as it enables pharmacists to interact with patients through the creation of a common platform for accessing data and information in a way that has not been possible before. Technology enables the storage of structured patient records, facilitates electronic prescribing, dispensing and administration of medicines, automates the handling of medicines in the supply chain, and provides tools for monitoring the efficacy and safety of medicines in use.

Ultimately, this enables pharmacists to contribute to the provision of high quality care.

Four main subtopics

– Enabling change – is your country ready?

Topic A will focus on change in developing and developed countries, education, workforce, advocacy, regulation, and the cost of change, as well as harnessing expertise from outside the world of pharmacy.

– Passion for pharmacy innovation, explore the global and start the personal

Topic B will look at scientifi c and technological innovation, and how these can be enabled by regulation.

– Ensuring a good health span for all

Topic C recognises that ensuring a healthy life requires a new focus on ill health prevention as well as disease treatment, and means people must take responsibility for their own health through self-care and digital tracking of their well-being.

– Targeting special interest

Topic D will target special interests in the difference fields of pharmacy and pharmaceutical sciences.